Company intelligence / Profile preview
Cumulus Oncology
Edinburgh, Scotland, United Kingdomcumulusoncology.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Cumulus Oncology accelerates the development of novel cancer therapies by identifying promising assets/targets, validating them through rigorous scientific review and experiments, then creating or supporting biotech spin-outs focused on these programs. The company aims to improve late-stage clinical success rates in oncology by de-risking opportunities early in development[1][2][5]. No specific clinical results are reported for Cumulus itself.
- Therapeutic areas
- Oncology
- Modalities
- Not explicitly listed; likely includes small molecules, biologics, and platform technologies in oncology based on their asset curation and partnerships[2].
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Notable partnerships include collaborations with academic institutions, commercial asset holders, and platform technology companies for access to new targets/assets in oncology drug development[1][2]. Specific partners are not publicly listed.
Beyond the preview
Go deeper on Cumulus Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cumulus Oncology.